We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 25 start-ups with an aggregate funding of $1.0b. The average funding per company in this subset is $41.8m.
Last update to the database: Feb 18, 2025. See changelog.
5
Funding Rounds
$103.1m
Money raised
Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.
4
Funding Rounds
$37.7m
Money raised
A synthetic biology company making agricultural biologicals.
5
Funding Rounds
$452.1m
Money raised
Inari is a biotechnology and agricultural technology company
1
Funding Rounds
$38.3m
Money raised
eTheRNA BVBA is a spin-off company from VUB. The company was created in 2013 by Prof. Kris Thielemans out of the Laboratory of Molecular and Cellular Therapy (LMCT). eTheRNA is currently focused on the manufacturing of mRNA based drugs/vaccines to support clinical development and diagnostic applications. The aim is to grow into a Flanders based biopharma company that will develop a leadership position in not only mRNA manufacturing but also developing mRNA based drugs that enhance the immunological response against certain targeted diseases/indications.
1
Funding Rounds
$10.4m
Money raised
Bone Therapeutics is a biotechnology company developing cell therapy treatments for orthopaedics and bone disease.
2
Funding Rounds
$52.2m
Money raised
Implantable pump systems provider to manage fluid balance within the body.
3
Funding Rounds
$49.7m
Money raised
OncoDNA is a Gosselies-based medical diagnostics company developing diagnostic products for cancer treatment.
1
Funding Rounds
$4.4m
Money raised
S-Biomedic brings novel therapeutic solutions to the skin microbiome. S-Biomedic uses a targeted modulation-based technology to modify the skin microbiome. This technology can be applied in both the dermatology and cosmetic industries.
2
Funding Rounds
$50.6m
Money raised
Agrosavfe is a Belgium-based company founded in 2013.
1
Funding Rounds
$20.8m
Money raised
Syndesi Therapeutics is a company developing molecules for the treatment of cognitive disorders of various neurological conditions.
4
Funding Rounds
$9.9m
Money raised
A company developing and marketing diagnostic and therapeutic anti-viral products for domesticated animals
1
Funding Rounds
$12.0m
Money raised
Ncardia is a stem Cell-related Services & Products founded in 2011.
3
Funding Rounds
$24.4m
Money raised
Complix is a Belgium-based company founded in 2008.
1
Funding Rounds
$56.6m
Money raised
Antibody therapies developer for oncology and auto-immune disease.
1
Funding Rounds
$4.7m
Money raised
Oncodesign is a preclinical services founded in 1995.
1
Funding Rounds
$39.2m
Money raised
Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.
2
Funding Rounds
$4.6m
Money raised
Platform for analyzing genetic data to drive innovation in precision medicine.
2
Funding Rounds
$8.9m
Money raised
A software platform for connecting seniors, healthcare staff, and family.
1
Funding Rounds
$14.5m
Money raised
reMYND is a preclinical In-Vivo Alzheimer's Contract Research.
1
Funding Rounds
$15.7m
Money raised
Rejuvenate Biomed is a Belgian based biomedical company engaged in developing prescription drugs in healthy ageing. By applying the progress made in geroscience (biology of aging) we identify and develop (up to POC) safe and well tolerated drugs that balance core biological processes associated with age-related functional decline.
1
Funding Rounds
$7.7m
Money raised
Sapreme Technologies is a macromolecule Therapies That Circumvent Endosomal Entrapment.
1
Funding Rounds
$14.0m
Money raised
BioMilk platform provider to produce goat milk proteins.
1
Funding Rounds
$5.4m
Money raised
BiocSol is a microbial pesticides producer founded in 2023.
1
Funding Rounds
$7.2m
Money raised
Rootwave is a company founded in 2014.
1
Funding Rounds
$1.6m
Money raised
4Tissue is a bioresorbable hydrogel technology developer for breast reconstruction founded in 2023 by Lana Van Damme.
Enter your email and get access to 71,000 + technology companies you can partner with.